EVT 

$0.000000
11
+$0.00+0%Monday 00:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Sep 2026
$0.16
Mar 2026
$0.13
Sep 2025
$0.14
Mar 2025
$0.10
Sep 2024
$0.14
10Y Growth
-2.16%
5Y Growth
N/A
3Y Growth
6.44%
1Y Growth
7.89%

Earnings

Feb 18Expected
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
Next
0.02
0.12
0.22
0.32
Expected EPS
0.3173133336223465
Actual EPS
N/A

Financials

3.93%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
869.28MRevenue
34.16MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EVHEF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap307B
Novartis is a global healthcare company that competes with EVT in the pharmaceutical and biotech sectors, particularly in drug discovery and development.
Pfizer
PFE
Mkt Cap167.52B
Pfizer is a large pharmaceutical company that competes with EVT in developing and commercializing drugs for various therapeutic areas.
Merck
MRK
Mkt Cap361.73B
Merck is a leading pharmaceutical company that competes with EVT in the research, development, and manufacturing of pharmaceuticals.
GSK
GSK
Mkt Cap100.88B
GlaxoSmithKline is a global healthcare company that competes with EVT in the pharmaceutical and vaccine markets.
Johnson & Johnson
JNJ
Mkt Cap664.95B
Johnson & Johnson is a diversified healthcare company that competes with EVT across several segments, including pharmaceuticals.
Abbvie
ABBV
Mkt Cap514.92B
AbbVie is a biopharmaceutical company that competes with EVT in developing advanced therapies for complex diseases.
AMGEN
AMGN
Mkt Cap249.05B
Amgen is a biotechnology company that competes with EVT in the discovery, development, and delivery of innovative medicines.
Bristol-Myers Squibb
BMY
Mkt Cap127.02B
Bristol Myers Squibb is a global biopharmaceutical company that competes with EVT in developing novel medicines for various diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a healthcare company that competes with EVT in pharmaceuticals and diagnostics, focusing on oncology, immunology, and infectious diseases.
Sanofi
SNY
Mkt Cap112.71B
Sanofi is a global healthcare leader that competes with EVT in providing therapeutic solutions in a wide range of medical fields.

About

EVT Limited, an Australian enterprise with its headquarters in Sydney, has been a significant player in the entertainment, hospitality, and leisure industries since its founding in 1910. The company, which rebranded from Event Hospitality & Entertainment Limited in October 2022, conducts its operations across Australia, New Zealand, and Germany. Its business is strategically divided into several key areas: Entertainment, Hotels and Resorts, Thredbo Alpine Resort, and Property and Other Investments. Within its Entertainment division, EVT manages a wide array of film exhibition venues, encompassing popular cinema brands like Event Cinemas, Moonlight Cinemas, Greater Union, and Birch, and Carroll & Coyle. It also administers the Cinebuzz Rewards loyalty program for moviegoers and oversees the operations of Sydney's iconic 2,000-seat State Theatre. Furthermore, this segment provides advanced technology solutions for the digital and electronic cinema as well as film projection sectors. The Hotels and Resorts arm features a portfolio of properties that EVT owns, operates, and manages under well-known brand names such as Rydges, QT, Atura, and the Thredbo Alpine brand, complemented by its Priority Guest Rewards program designed for hotel guests. Beyond these core areas, the company's Property and Other Investments segment actively engages in real estate development and investment, alongside holding strategic equity stakes in various unlisted businesses.
Show More
CEO
Jane Megan Hastings
Employees
10000
Country
Australia
ISIN
AU000000EVT1
WKN
000A2ACRX

Listings

0 Comments

Share your thoughts

FAQs

What is EVT stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange EVT stocks are traded under the ticker EVHEF.
When is the next EVT earnings date?▼
EVT is going to release the next earnings report on February 18, 2027.
What were EVT earnings last quarter?▼
EVHEF earnings for the last quarter are 0.06 USD per share, whereas the estimation was 0.06 USD resulting in a +1.5% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is EVT revenue for the last year?▼
EVT revenue for the last year amounts to 869.28M USD.
What is EVT net income for the last year?▼
EVHEF net income for the last year is 34.16M USD.
Does EVT pay dividends?▼
Yes, EVHEF dividends are paid semi-annual. The last dividend per share was 0.16 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does EVT have?▼
As of November 10, 2026, the company has 10,000 employees.
In which sector is EVT located?▼
EVT operates in the Communication sector.
When did EVT complete a stock split?▼
EVT has not had any recent stock splits.
Where is EVT headquartered?▼
EVT is headquartered in Sydney, Australia.